Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Envoy Medical, Inc. - Class A Common Stock (NQ: COCH ) 2.550 -0.100 (-3.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Envoy Medical, Inc. - Class A Common Stock < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Friday's After-Market Session November 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 01, 2024 Via Benzinga Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device November 01, 2024 From Envoy Medical, Inc Via GlobeNewswire Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage October 24, 2024 From Envoy Medical, Inc Via GlobeNewswire Envoy Medical to Present at the LD Micro Main Event XVII October 23, 2024 From Envoy Medical, Inc Via GlobeNewswire American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device October 22, 2024 From Envoy Medical, Inc Via GlobeNewswire Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market October 01, 2024 From Envoy Medical, Inc Via GlobeNewswire Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company September 23, 2024 From Envoy Medical, Inc Via GlobeNewswire Envoy Medical Awarded Patent for Recharge System used with Implantable Battery September 16, 2024 From Envoy Medical, Inc Via GlobeNewswire Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying September 12, 2024 Via Benzinga Envoy Medical Secures Lending Facility of $10M August 28, 2024 From Envoy Medical, Inc Via GlobeNewswire COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024 August 12, 2024 COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage July 31, 2024 From Envoy Medical, Inc Via GlobeNewswire Envoy Medical Announces Inclusion in the Russell Microcap Index July 01, 2024 From Envoy Medical, Inc Via GlobeNewswire Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling June 11, 2024 From Envoy Medical, Inc Via GlobeNewswire Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index June 06, 2024 From Envoy Medical, Inc Via GlobeNewswire Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology June 05, 2024 From Envoy Medical, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 21, 2024 Via Benzinga COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024 May 15, 2024 COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 07, 2024 Via Benzinga Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024 April 24, 2024 From Envoy Medical, Inc Via GlobeNewswire ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH April 22, 2024 From The Rosen Law Firm PA Via GlobeNewswire COCH INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH April 21, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire COCH INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH April 21, 2024 WHY: NEW YORK, NY - (NewMediaWire) - April 21, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical,... Via TheNewswire.com ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH April 18, 2024 From The Rosen Law Firm PA Via GlobeNewswire COCH INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH April 17, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire COCH INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH April 17, 2024 WHY: NEW YORK, NY - (NewMediaWire) - April 17, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical,... Via TheNewswire.com ROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH April 15, 2024 From The Rosen Law Firm PA Via GlobeNewswire Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
